Avadel Pharmaceuticals
AVDL
#5962
Rank
S$1.03 B
Marketcap
$10.52
Share price
-2.25%
Change (1 day)
-53.16%
Change (1 year)

Revenue for Avadel Pharmaceuticals (AVDL)

Revenue in 2024 (TTM): S$0.22 Billion

According to Avadel Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is S$0.22 Billion. an increase over the revenue in the year 2023 that were of S$36.93 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Avadel Pharmaceuticals from 1996 to 2024

20002005201020152020$50M$0.1B$0.15B$0.2B0companiesmarketcap.com

Annual revenue

Year Revenue Change
2024 S$0.22 B522.45%
2023 S$36.93 M
2022 N/A
2021 N/A-100%
2020 S$29.54 M-62.99%
2019 S$79.83 M-43.41%
2018 S$0.14 B-39.11%
2017 S$0.23 B6.56%
2016 S$0.21 B-10.63%
2015 S$0.24 B2770.91%
2014 S$8.47 M-70.19%
2013 S$28.43 M-10.92%
2012 S$31.91 M-24.4%
2011 S$42.21 M-11.64%
2010 S$47.78 M-19.19%
2009 S$59.12 M7.06%
2008 S$55.22 M4.71%
2007 S$52.74 M49.42%
2006 S$35.29 M-10.16%
2005 S$39.29 M-64.97%
2004 S$0.11 B166.22%
2003 S$42.13 M32.25%
2002 S$31.85 M31.5%
2001 S$24.22 M30.32%
2000 S$18.58 M1.11%
1999 S$18.38 M16.95%
1998 S$15.72 M16.55%
1997 S$13.48 M96.69%
1996 S$6.85 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
S$0.3 M-99.87%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.95 B 321.69%๐Ÿ‡บ๐Ÿ‡ธ USA